Sparse Batch Number Reporting for Biologicals in FDA's Adverse Event Reporting System (AERS)

被引：0
|
作者：
Vermeer, N. S. [1 ,2 ]
Straus, S. M. [2 ,3 ]
Teeuwisse, A. K. Mantel [1 ]
Egberts, T. C. [1 ]
Leufkens, H. G. [1 ,2 ]
De Bruin, M. L. [1 ,2 ]
机构：
[1] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, UIPS, Utrecht, Netherlands
[2] Med Evaluat Board, The Hague, Netherlands
[3] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
来源：
DRUG SAFETY | 2011年 / 34卷 / 10期
关键词：
BIOPHARMACEUTICALS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
下载
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [41] Spontaneous reporting of rare events associated with atypical antipsychotics using the FDA adverse event reporting system
    Emechebe, Nnadozie
    Mukhtar, Fahad
    Scheer, Darren
    Patel, Arshiya
    Wadhawan, Abhishek
    Schwartz, Skai
    Zgibor, Janice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 345 - 346
  • [42] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system
    Huang, Qing
    Wu, Yuanbin
    Li, Huimin
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [44] Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
    Byskov, Pernille Kahler
    Baden, Christoffer Storm
    Andersen, Jon Traerup
    Jimenez-Solem, Espen
    Olsen, Ramus Huan
    Gade, Christina
    Lausten-Thomsen, Ulrik
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Introduction of a Mobile Adverse Event Reporting System Is Associated With Participation in Adverse Event Reporting
    Rubin, Daniel S.
    Pesyna, Colin
    Jakubczyk, Sharon
    Liao, Chuanhong
    Tung, Avery
    AMERICAN JOURNAL OF MEDICAL QUALITY, 2019, 34 (01) : 30 - 35
  • [46] Missing data in FDA adverse event reporting systems
    Smith, Sheila Weiss
    Gogolak, Victor V.
    Deshpande, Gaurav
    Chung, Stephanie
    Mehta, Shekhar H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S72 - S72
  • [47] Patient Relevant Outcomes Associated with Generic Drugs in FDA's Adverse Event Reporting System
    Marimuthu, Sathiya Priya
    Iyer, Geetha S.
    Segal, Jodi B.
    Singh, Sonal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 421 - 422
  • [48] Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System
    Carnovale, Carla
    Gentili, Marta
    Vigano, Caterina
    Carnaghi, Giulia
    Beltrami, Marta
    Bosi, Monica
    PHARMACOLOGICAL RESEARCH, 2019, 141 : 616 - 617
  • [49] Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
    Yibei Zhao
    Huiming Jiang
    Lifen Xue
    Mi Zhou
    Xiaobing Zhao
    Fei Liu
    SongJiang Jiang
    Jing Huang
    Long Meng
    International Journal of Clinical Pharmacy, 2024, 46 : 480 - 487
  • [50] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
12345